- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Orchid Pharma Ltd (ORCD)
Orchid Pharma Ltd stock price live, this page displays NSE ORCD stock exchange data. View the ORCD premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Orchid Pharma Ltd real time stock price chart below.
What Is the Orchid Pharma Ltd Stock Price Today?
The Orchid Pharma Ltd stock price today is 758.45.
What Is the Stock Symbol for Orchid Pharma Ltd?
The stock symbol for Orchid Pharma Ltd is ""ORCD.""
What Stock Exchange Does Orchid Pharma Ltd Trade On?
Orchid Pharma Ltd is listed and trades on the NSE stock exchange.
Is Orchid Pharma Ltd a Good Stock to Buy?
Determining whether Orchid Pharma Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ORCD quote. (ISIN: INE191A01027)
What Is the Orchid Pharma Ltd Stock Price Today?
The Orchid Pharma Ltd stock price today is 758.45.
What Is the Stock Symbol for Orchid Pharma Ltd?
The stock symbol for Orchid Pharma Ltd is ""ORCD.""
What Stock Exchange Does Orchid Pharma Ltd Trade On?
Orchid Pharma Ltd is listed and trades on the NSE stock exchange.
Is Orchid Pharma Ltd a Good Stock to Buy?
Determining whether Orchid Pharma Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ORCD quote. (ISIN: INE191A01027)
758.45
+0.40(+0.05%)
Closed·
Fair Value
An estimate of a Orchid Pharma Ltd's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
739.30
765.85
52 wk Range
603.80
1,998.00
ORCD Scorecard
Full Analysis
Analysts anticipate sales growth in the current year
Earnings results expected in 3 days
1/2
Fair Value
An estimate of a Orchid Pharma Ltd's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
739.30765.85
52 wk Range
603.801,998.00
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
ORCD Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Orchid Pharma Ltd's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Trading at a high P/E ratio relative to near-term earnings growth
- Orchid Pharma Ltd receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Orchid Pharma Ltd receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Orchid Pharma Ltd receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Orchid Pharma Ltd receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- Orchid Pharma Ltd receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Orchid Pharma Ltd receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Orchid Pharma Ltd receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Orchid Pharma Ltd receives Investment Bank Analyst Rating Update
- Investing.com
Pro
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Sell
Moving Averages
Buy
Orchid Pharma Ltd Company Profile
Orchid Pharma Limited, a pharmaceutical company, engages in the development, manufacture, and marketing of active pharmaceutical ingredients, bulk actives, finished dosage formulations, and nutraceuticals in India. Its active pharmaceutical ingredients product portfolio includes oral cephalosporins, injectable cephalosporins, veterinary products, and non-antibiotics. The company has multi-therapeutic presence in anti-infectives, anti-inflammatory, central nervous system, cardiovascular segment, nutraceuticals, and other oral and sterile products, as well as offers new drug discovery systems and pharmaceutical research and development services. It also exports its products to approximately 40 countries internationally. The company was formerly known as Orchid Chemicals & Pharmaceuticals Limited and changed its name to Orchid Pharma Limited in October 2015. Orchid Pharma Limited was incorporated in 1992 and is based in Narsinghpur, India. Orchid Pharma Limited operates as a subsidiary of Dhanuka Laboratories Limited.
Compare ORCD to Peers and Sector
Metrics to compare | ORCD | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipORCDPeersSector | |
|---|---|---|---|---|
P/E Ratio | 38.4x | 12.2x | −0.5x | |
PEG Ratio | 12.33 | 0.11 | 0.00 | |
Price/Book | 3.0x | 1.2x | 2.6x | |
Price / LTM Sales | 4.2x | 1.0x | 3.3x | |
Upside (Analyst Target) | 30.5% | 21.4% | 43.5% | |
Fair Value Upside | Unlock | 12.6% | 6.8% | Unlock |
Earnings
Latest Release
May 26, 2025
EPS / Forecast
4.40 / --
Revenue / Forecast
2.38B / --
People Also Watch
FAQ
What Stock Exchange Does Orchid Pharma Ltd Trade On?
Orchid Pharma Ltd is listed and trades on the Bombay Stock Exchange stock exchange.
What Is the Stock Symbol for Orchid Pharma Ltd?
The stock symbol for Orchid Pharma Ltd is "ORCD."
What Is the Orchid Pharma Ltd Market Cap?
As of today, Orchid Pharma Ltd market cap is 38.29B.
What Is Orchid Pharma Ltd's Earnings Per Share (TTM)?
The Orchid Pharma Ltd EPS (TTM) is 19.65.
When Is the Next Orchid Pharma Ltd Earnings Date?
Orchid Pharma Ltd will release its next earnings report on 11 Aug 2025.
From a Technical Analysis Perspective, Is ORCD a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Orchid Pharma Ltd Stock Split?
Orchid Pharma Ltd has split 2 times.
How Many Employees Does Orchid Pharma Ltd Have?
Orchid Pharma Ltd has 871 employees.
What is the current trading status of Orchid Pharma Ltd (ORCD)?
As of 09 Aug 2025, Orchid Pharma Ltd (ORCD) is trading at a price of 758.45, with a previous close of 758.05. The stock has fluctuated within a day range of 739.30 to 765.85, while its 52-week range spans from 603.80 to 1,998.00.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.